{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:20:42Z","timestamp":1773832842914,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11255-020-02418-w","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T15:02:51Z","timestamp":1584111771000},"page":"791-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis"],"prefix":"10.1007","volume":"52","author":[{"given":"Hatem","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen El","family":"Kossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Pararajasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Halawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"2418_CR1","first-page":"350","volume":"127","author":"RS Gaston","year":"2016","unstructured":"Gaston RS (2016) Improving long-term outcomes in kidney transplantation: towards a new paradigm of post-transplant care in the united states. Trans Am Clin Climatol Assoc 127:350\u2013361","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"8","key":"2418_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/tri.12553","volume":"28","author":"J Bamoulid","year":"2015","unstructured":"Bamoulid J, Staeck O, Halleck F et al (2015) The need for minimization strategies: current problems of immunosuppression. Trans Int 28(8):891\u2013900","journal-title":"Trans Int"},{"issue":"11","key":"2418_CR3","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/ctr.12837","volume":"30","author":"S Hussain","year":"2016","unstructured":"Hussain S, Knight SR (2016) Quality and consistency of outcome reporting in clinical trials of immunosuppression in renal transplantation. Clin Trans 30(11):1440\u20131448","journal-title":"Clin Trans"},{"issue":"1","key":"2418_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1319-2442.124459","volume":"25","author":"S Kesiraju","year":"2014","unstructured":"Kesiraju S, Paritala P, Rao Ch UM, Athmakuri SM, Reddy VS, Sahariah S (2014) Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome. Saud J Kidney Dis Trans 25(1):9\u201315","journal-title":"Saud J Kidney Dis Trans"},{"issue":"1","key":"2418_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0041-1345(02)03895-2","volume":"35","author":"RK Sharma","year":"2003","unstructured":"Sharma RK, Kumar A, Kumar J et al (2003) Low-dose ATG is effective in treatment of acute rejection episodes. Trans Proc 35(1):225\u2013226","journal-title":"Trans Proc"},{"issue":"6","key":"2418_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2215\/CJN.03800415","volume":"10","author":"AC Wiseman","year":"2015","unstructured":"Wiseman AC (2015) Induction therapy in renal transplantation: Why? What agent? What dose? We may never know. Clin J Am Soc Nephrol 10(6):923\u2013925","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2418_CR7","doi-asserted-by":"publisher","first-page":"eAO4278","DOI":"10.31744\/einstein_journal\/2018AO4278","volume":"16","author":"FP Machado","year":"2018","unstructured":"Machado FP, Vicari AR, Spuldaro F, Castro Filho JBSd, Manfro RC (2018) Polyclonal anti T-lymphocyte antibody therapy monitoring in kidney transplant recipients: comparison of CD3+ T cell and total lymphocyte counts. Einstein 16(4):eAO4278\u2013eAO4278 (Sao Paulo, Brazil)","journal-title":"Einstein"},{"issue":"8","key":"2418_CR8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/ndt\/gfu079","volume":"29","author":"AP Bouvy","year":"2014","unstructured":"Bouvy AP, Klepper M, Kho MM et al (2014) The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients. Nephrol Dial Trans 29(8):1587\u20131597","journal-title":"Nephrol Dial Trans"},{"issue":"6","key":"2418_CR9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1681\/ASN.2009040389","volume":"20","author":"D Mandelbrot","year":"2009","unstructured":"Mandelbrot D (2009) Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation. J Am Soc Nephrol 20(6):1170\u20131171","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 3","key":"2418_CR10","first-page":"S1","volume":"9","author":"Kidney Disease: Improving Global Outcomes Transplant Work G","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes Transplant Work G (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9(Suppl 3):S1\u2013155","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"2418_CR11","doi-asserted-by":"publisher","first-page":"c311","DOI":"10.1159\/000328074","volume":"118","author":"R Baker","year":"2011","unstructured":"Baker R, Jardine A, Andrews P (2011) Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. Nephron Clin Pract 118(Suppl 1):c311\u2013c347","journal-title":"Nephron Clin Pract"},{"key":"2418_CR12","doi-asserted-by":"crossref","unstructured":"Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC (2005) Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. (4):003961","DOI":"10.1002\/14651858.CD003961.pub2"},{"issue":"9270","key":"2418_CR13","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(00)04934-5","volume":"357","author":"M Clarke","year":"2001","unstructured":"Clarke M, Horton R (2001) Bringing it all together: Lancet-Cochranecollaborate on systematic reviews. Lancet 357(9270):1728","journal-title":"Lancet"},{"issue":"15","key":"2418_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008","journal-title":"JAMA"},{"issue":"5","key":"2418_CR15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/SLA.0000000000000496","volume":"259","author":"NA Pilch","year":"2014","unstructured":"Pilch NA, Taber DJ, Moussa O et al (2014) Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg 259(5):888\u2013893","journal-title":"Ann Surg"},{"issue":"10063","key":"2418_CR16","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","volume":"388","author":"O Thomusch","year":"2016","unstructured":"Thomusch O, Wiesener M, Opgenoorth M et al (2016) Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial. Lancet (London, England) 388(10063):3006\u20133016","journal-title":"Lancet (London, England)"},{"issue":"6","key":"2418_CR17","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1681\/ASN.2008101037","volume":"20","author":"C Noel","year":"2009","unstructured":"Noel C, Abramowicz D, Durand D et al (2009) Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol 20(6):1385\u20131392","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2418_CR18","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1016\/j.transproceed.2010.08.045","volume":"42","author":"G Ciancio","year":"2010","unstructured":"Ciancio G, Gaynor JJ, Roth D et al (2010) Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation. Trans Proc 42(9):3503\u20133506","journal-title":"Trans Proc"},{"key":"2418_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1399-0012.2007.00774.x","volume":"22","author":"G Ciancio","year":"2008","unstructured":"Ciancio G, Burke GW, Gaynor JJ et al (2008) A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up. Clin Transplant 22:200\u2013210","journal-title":"Clin Transplant"},{"issue":"6","key":"2418_CR20","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0041-1345(03)00679-1","volume":"35","author":"SG Tullius","year":"2003","unstructured":"Tullius SG, Pratschke J, Strobelt V et al (2003) ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results. Transplant Proc 35(6):2100\u20132101","journal-title":"Transplant Proc"},{"issue":"3","key":"2418_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s10157-017-1480-z","volume":"22","author":"K Wang","year":"2018","unstructured":"Wang K, Xu X, Fan M (2018) Induction therapy of basiliximab versus antithymocyte globulin in renal allograft: a systematic review and meta-analysis. Clin Exp Nephrol 22(3):684\u2013693","journal-title":"Clin Exp Nephrol"},{"issue":"21","key":"2418_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1056\/NEJM200011233432107","volume":"343","author":"CJ Young","year":"2000","unstructured":"Young CJ, Gaston RS (2000) Renal transplantation in black Americans. N Engl J Med 343(21):1545\u20131552","journal-title":"N Engl J Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02418-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-020-02418-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02418-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:21:04Z","timestamp":1615594864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-020-02418-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02418-w","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards of Liverpool university research committee and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}